Recorded Presentation from the 2016 NCCN Nursing Program Webinar Series - Clinical Updates and Issues: Relapsed/Refractory Multiple Myeloma

The NCCN 2016 Oncology Nursing Program Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care. Information is focused on current and critical issues to provide oncology nurses with practical information that can be implemented in the practice setting.

Target Audience

This activity is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Learning Objectives

Following this program, participants should be able to:

  • Identify advances in systemic treatment of relapsed/refractory multiple myeloma.
  • Describe the complexities in treating relapsed/refractory multiple myeloma.
  • Recognize and manage adverse events associated with therapies used to treat relapsed/refractory multiple myeloma.
Additional information
Supporters: 

Supported by educational grants from AstraZeneca; Celgene Corporation; Clovis Oncology; Genentech; Lilly; Novartis Oncology; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC; and Pfizer. Supported by an independent educational grant from Merck. This activity is supported by educational funding provided by Amgen.

Course summary
Available credit: 
  • 0.86 ANCC contact hours
  • 0.86 Participation
Course opens: 
06/28/2016
Course expires: 
06/28/2017
Cost:
$0.00
United States

Beth Faiman, PhD, MSN, APRN-BC, AOCN
Cleveland Clinic Taussig Cancer Institute

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Faculty Disclosures
The faculty listed below have disclosed the following relevant financial relationships:

Beth Faiman, PhD, MSN, APRN-BC, AOCN
Amgen: Consultant
Celgene: Consultant
Takeda Oncology: Consultant

Her presentation will not include discussion of investigational or unlabeled uses of commercial products.

NCCN Staff Disclosures
The activity planning staff listed below has no relevant financial relationships to disclose:
Ann Gianola, MA; Mark Geisler; Kristina M. Gregory, RN, MSN, OCN; Kristin Kline Hasson; Rose Joyce; Joan S. McClure, MS; Diane McPherson; Deborah Moonan, RN, BSN; Lisa Perfidio; Liz Rieder; Shannon K. Ryan; Kathy Smith; Jennifer Weckesser

The activity planning staff listed below has disclosed the following relevant financial relationships:

Mercedes De La Hoz
Pfizer Inc.: Other financial benefit

The NCCN clinical information team listed below, who has reviewed content, has no relevant financial relationships to disclose:
Rashmi Kumar, PhD

The ACCME/ANCC/ACPE defines “conflict of interest” as when an individual has an opportunity to affect CE content about products or services of a commercial interest with which he/she has a financial relationship.

ACCME, ACPE, and ANCC focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CE activity. ACCME, ACPE, and ANCC have not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME, ACPE, and ANCC defines “’relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation to the tasks and methods of delivery.

National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation. NCCN designates this educational activity for a maximum of 0.86 contact hours. Accreditation as a provider refers to the recognition of educational activities only; accredited status does not imply endorsement by NCCN or ANCC of any commercial products discussed/displayed in conjunction with the educational activity.

Kristina M. Gregory, RN, MSN, OCN, is our lead nurse planner for this educational activity.

Available Credit

  • 0.86 ANCC contact hours
  • 0.86 Participation

Accreditation Period

Course opens: 
06/28/2016
Course expires: 
06/28/2017

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Flash Player and/or an HTML5 capable browser for video or audio playback
  • Adobe Reader or other PDF reader software for certificate viewing/printing